GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Price-to-Owner-Earnings

Alto Neuroscience (Alto Neuroscience) Price-to-Owner-Earnings : (As of May. 26, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Price-to-Owner-Earnings?

As of today (2024-05-26), Alto Neuroscience's share price is $12.92. Alto Neuroscience does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Alto Neuroscience's Price-to-Owner-Earnings or its related term are showing as below:


ANRO's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.37
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-26), Alto Neuroscience's share price is $12.92. Alto Neuroscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.20. Therefore, Alto Neuroscience's PE Ratio for today is At Loss.

As of today (2024-05-26), Alto Neuroscience's share price is $12.92. Alto Neuroscience's EPS without NRI for the trailing twelve months (TTM) ended in was $-1.19. Therefore, Alto Neuroscience's PE Ratio without NRI for today is At Loss.


Alto Neuroscience Price-to-Owner-Earnings Historical Data

The historical data trend for Alto Neuroscience's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Price-to-Owner-Earnings Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - -

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Alto Neuroscience's Price-to-Owner-Earnings

For the Biotechnology subindustry, Alto Neuroscience's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alto Neuroscience's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alto Neuroscience's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Alto Neuroscience's Price-to-Owner-Earnings falls into.



Alto Neuroscience Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Alto Neuroscience's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=12.92/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alto Neuroscience  (NYSE:ANRO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Alto Neuroscience Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Alto Neuroscience (Alto Neuroscience) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus